Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 874

1.

[Primary biliary cholangitis : an update].

Vieira Barbosa J, Vionnet J, Sciarra A, Sempoux C, Aubert V, Moradpour D, Fraga Christinet M.

Rev Med Suisse. 2018 Aug 29;14(616):1489-1494. French.

PMID:
30156781
2.

Adipokine interactions promote the pathogenesis of systemic lupus erythematosus.

Chougule D, Nadkar M, Venkataraman K, Rajadhyaksha A, Hase N, Jamale T, Kini S, Khadilkar P, Anand V, Madkaikar M, Pradhan V.

Cytokine. 2018 Aug 8;111:20-27. doi: 10.1016/j.cyto.2018.08.002. [Epub ahead of print]

PMID:
30098476
3.

A study of prevalence of autoantibodies in patients with lichen planus from Mumbai, India.

Rambhia KD, Kharkar V, Pradhan V, Patwardhan M, Ghosh K, Khopkar US.

Indian J Dermatol Venereol Leprol. 2018 Jul 23. doi: 10.4103/ijdvl.IJDVL_182_17. [Epub ahead of print]

PMID:
30058559
4.

Autoimmune associations in a Mexican cohort with primary biliary cholangitis.

González-Huezo MS, Delgado-Ayala LY, Osorio-Núñez AL, Meléndez-Mercado C.

Rev Gastroenterol Mex. 2018 Jul 13. pii: S0375-0906(18)30126-5. doi: 10.1016/j.rgmx.2018.03.008. [Epub ahead of print] English, Spanish.

5.

Vitiligo and autoantibodies: a systematic review and meta-analysis.

Liu CW, Huang YC.

J Dtsch Dermatol Ges. 2018 Jul;16(7):845-851. doi: 10.1111/ddg.13574. Epub 2018 Jul 4. Review.

PMID:
29972626
6.

A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.

Nguyen HH, Khathlan A, Fritzler MJ, Swain MG.

BMC Gastroenterol. 2018 Jun 25;18(1):97. doi: 10.1186/s12876-018-0826-7.

7.

Rituximab is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A phase-2 Randomised Controlled Trial.

Khanna A, Jopson L, Howel D, Bryant A, Blamire A, Newton JL, Jones DE.

Hepatology. 2018 May 23. doi: 10.1002/hep.30099. [Epub ahead of print]

PMID:
29790196
8.

Corticosteroid Therapy Improves the Outcome of Autoimmune Hepatitis-Induced Acute Liver Failure.

Anastasiou OE, Dogan-Cavus B, Kucukoglu O, Baba H, Kahraman A, Gerken G, Schramm C, Canbay A.

Digestion. 2018;98(2):104-111. doi: 10.1159/000487940. Epub 2018 Apr 26.

PMID:
29698940
9.

Comment on: Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Ceribelli A, Isailovic N, De Santis M, Selmi C.

Semin Arthritis Rheum. 2018 Mar 28. pii: S0049-0172(18)30153-7. doi: 10.1016/j.semarthrit.2018.03.014. [Epub ahead of print] No abstract available.

PMID:
29685483
10.

Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.

Sebode M, Weiler-Normann C, Liwinski T, Schramm C.

Front Immunol. 2018 Mar 27;9:609. doi: 10.3389/fimmu.2018.00609. eCollection 2018. Review.

11.

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.

Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ.

Gut. 2018 Sep;67(9):1568-1594. doi: 10.1136/gutjnl-2017-315259. Epub 2018 Mar 28.

12.

Primary biliary cholangitis.

Parés A.

Med Clin (Barc). 2018 Sep 21;151(6):242-249. doi: 10.1016/j.medcli.2017.12.021. Epub 2018 Mar 9. Review. English, Spanish.

PMID:
29526309
14.

Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma.

Ide R, Oshita A, Nishisaka T, Nakahara H, Aimitsu S, Itamoto T.

World J Hepatol. 2017 Dec 28;9(36):1378-1384. doi: 10.4254/wjh.v9.i36.1378.

15.

[How to understand the clinical significance of autoantibodies in primary biliary cholangitis].

Yan HP, Zhang HP, Chen XX.

Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):810-815. doi: 10.3760/cma.j.issn.1007-3418.2017.11.003. Chinese.

PMID:
29325273
16.

Anti-mitochondrial M2 Antibodies and Myopathy.

Finsterer J, Zarrouk-Mahjoub S.

Intern Med. 2018 Apr 15;57(8):1187. doi: 10.2169/internalmedicine.9878-17. Epub 2017 Dec 27. No abstract available.

17.

Primary biliary cholangitis: a comprehensive overview.

Lleo A, Marzorati S, Anaya JM, Gershwin ME.

Hepatol Int. 2017 Nov;11(6):485-499. doi: 10.1007/s12072-017-9830-1. Epub 2017 Nov 21. Review.

PMID:
29164395
18.

Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.

Joshita S, Umemura T, Tanaka E, Ota M.

Clin J Gastroenterol. 2018 Feb;11(1):11-18. doi: 10.1007/s12328-017-0799-z. Epub 2017 Nov 20. Review.

PMID:
29159718
19.

A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization.

Ma WT, Liu QZ, Yang JB, Yang YQ, Zhao ZB, Ma HD, Gershwin ME, Lian ZX.

Sci Rep. 2017 Nov 10;7(1):15246. doi: 10.1038/s41598-017-15661-6.

20.

Less Limb Muscle Involvement in Myositis Patients with Anti-Mitochondrial Antibodies.

Uenaka T, Kowa H, Ohtsuka Y, Seki T, Sekiguchi K, Kanda F, Toda T.

Eur Neurol. 2017;78(5-6):290-295. doi: 10.1159/000481503. Epub 2017 Oct 19.

PMID:
29049993

Supplemental Content

Loading ...
Support Center